📢 Latest Update: UGC Discontinues CARE Journal Listing: New Guidelines for Selecting Peer-Reviewed Journals View Now

Research and Reviews: A Journal of Pharmacology Cover

Research and Reviews: A Journal of Pharmacology

E-ISSN: 2230-9861 | P-ISSN: 2349-1299 | Peer-Reviewed Journal (Refereed Journal) | Hybrid Open Access

About the Journal

Research and Reviews: A Journal of Pharmacology

Research & Reviews: A Journal of Pharmacology [2230-9861(e)] is a peer-reviewed hybrid open-access journal launched in 2011 and focused on the rapid publication of fundamental research papers on all areas of Pharmacology.

View full focus & scope More

Journal Information

Title: Research and Reviews: A Journal of Pharmacology
Abbreviation: rrjop
Issues Per Year: 3 Issues
P-ISSN: 2349-1299
E-ISSN: 2230-9861
Publisher: STM Journals, An imprint of Consortium e-Learning Network Pvt. Ltd.
DOI: 10.37591/RRJoP
Starting Year: 2011
Subject: Pharmacology
Publication Format: Hybrid Open Access
Language: English
Copyright Policy: CC BY-NC-ND
Type: Peer-reviewed Journal (Refereed Journal)

Address:

STM Journals, An imprint of Consortium e-Learning Network Pvt. Ltd. A-118, 1st Floor, Sector-63, Noida, U.P. India, Pin - 201301

Editorial Board

View Full Editorial Board

rrjop maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Editor in Chief

Editor

Dr. Laxmikant Borse, Principal

Sandip Institute of Pharmaceutical Sciences, Nashik, Maharashtra, India, 422213

Email :

Latest Articles

Ahead of Print

Non-Small Cell Lung Cancer: Types, Pathogenesis, Diagnosis, and Novel Therapeutic Strategies

Non-small cell lung cancer (NSCLC) is the most prevalent type of lung cancer, accounting for over 85% of all cases globally.

Non-small cell lung cancer (NSCLC), Adenocarcinoma, Squamous cell carcinoma, Large cell carcinoma, Lung Cancer, Targeted Therapy, EGFR Inhibitors, ALK inhibitors, Immunotherapy, Precision medicine, Molecular profiling, Diagnosis, Pathogenesis, Chemotherapy, Antibody-drug conjugates (ADCs)

Pharmacodynamics and Drug–Receptor Interactions: Integrating PK/PD Modeling with Modern Drug Development

Understanding drug action requires an integrated perspective of pharmacodynamics and pharmacokinetics, which together determine therapeutic efficacy and safety.

Pharmacodynamics (PD), Drug metabolism ADME, Drug development, Systems pharmacology, drugs interaction, biochemical effects.

Evaluation of Anti-cataract Potential of Carbocisteine by Using In Vitro Goat Lens Model

This study includes Carbocisteine has four Oxygen molecules, one Sulfur molecule, and one Nitrogen molecule.

Anti-cataract, Carbocisteine, Artificial aqueous humour, In-vitro, goat lens

Evaluation of Anti-cataract Potential of Carbocisteine by Using In Vitro Goat Lens Model

This study includes Carbocisteine has four Oxygen molecules, one Sulfur molecule, and one Nitrogen molecule.

Anti-cataract, Carbocisteine, Artificial aqueous humour, In-vitro, goat lens

In Silico Screening and Molecular Docking of Cynodon dactylon phytochemicals against COPD-Associated Proteins

Chronic Obstructive Pulmonary Disease or COPD is a pulmonary disease that obstructs airways and alveoli accompanied by respiratory issues like emphysema and bronchitis.

COPD, emphysema, bronchitis, tobacco smoke, inflammation, Cynodon dactylon, anti-inflammatory, in silico, molecular docking

Modern Approaches in Lung Cancer Management from Herbal Nanomedicine to Artificial Intelligence

Lung cancer continues to be a major global health concern and one of the leading causes of cancer-related mortality worldwide.

Lung Cancer, Herbal Medicine, Nanoparticles, Artificial Intelligence, Lung Cancer Biomarkers.